Some have scoffed at the idea of California spear-heading a

New Post Public Reply Private Reply Replies (0) Message Board
MoneyForNuthin
Some have scoffed at the idea of California spear-heading a ban on isocyanates, suggesting that California will ban the air we breath, given the opportunity. LOL, see "Recent Anti-Isocyanate Regulatory Pressure" at the bottom of this post, as well as the various links herein showing worldwide concerns regarding isocyanates. BTW, do you know anyone with asthma? Watch the isocyanate-asthma video in the links section, read some of the links.

Is Hybrid Coating Technologies' (HCTI) isocyanate-free Green Polyurethane™ Solution a solution looking for a problem, or is there a real need? Did polyurethane become the new "miracle material" to follow in the footsteps of asbestos? Check out some of the links at the bottom of this post, and you may agree that it's probably a really good idea to eliminate the toxic isocyanate component from the formulation/process as soon as possible.

From 2010 through 2013, Hybrid Coating Technologies (HCTI) reported as a Development Stage Entity (FASB). Since 2014, HCTI has been commercializing the isocyanate-free product, and recently just started lining up formulation and distribution partners. Product is just now becoming available in off-the-shelf inventory.

Hybrid Coating Technologies Inc. (HCTI) is a fully compliant "SEC Reporting - Current" company trading on the OTCBB, filing audited annual reports.

A/S = 1.6B shares
O/S = 704,330,491 (November 20, 2015)
Current PPS = 0.0024 (February 26, 2016)
Market Cap (last reported O/S) = $1.69M

Current Situation - my opinion only, do your own DD, make your own decisions and trade at your own risk! [list][*]Greatly undervalued at current price - price is depressed due to debt accumulation and dilution during Development Phase and early Commercialization/Marketing Phase; Enterprise Value (inclusive of debt) is currently ~$10M and, IMHO, should easily be several 10's of $M[*]Commercializing, sub-licensing with semi-exclusivity and marketing the isocyanate-free PU product.[*]Recent contracts include a $4M over 3 years minimum buy agreement with Industrial Finishes and "up to" $20M per annum agreement with Fortune 500 partner[*]Servicing debt accumulated during the Development Phase and beginning of Commercialization & Marketing Phase - expect multiple accumulation opportunities with price correction plateaus (consolidation) and small pullbacks during dilutive debt-conversion share selling periods as price corrects upward in stair step fashion toward fair market value.[*]Just beginning to execute contracts and accept revenue-generating orders - current active projects with 5 Fortune 500 companies and developing new relationships with others[/list] "We are the exclusive licensee of Green Polyurethane™ foam, coatings, and adhesives – the world’s first-ever patent protected polyurethane-based foam, coatings, and adhesive products that eliminate toxic isocyanates from the entire production process (licensed by Nanotech Industries, Inc.) and the 2015 recipient of the Presidential Green Chemistry Award."

O/S - latest "guess" is ballpark of 1B+ (will be updated again with 10-K due end of March, or more likely mid-April with "late" extension)
Market Cap - with O/S fully diluted to A/S of 1.6B, Market Cap = $3.84M

$HCTI Hybrid Coating Technologies Inc. Investor Presentation

See latest news:
http://www.otcmarkets.com/stock/HCTI/news

See latest filings:
http://www.otcmarkets.com/stock/HCTI/filings

Change begins when solutions are imminent, starting with recommendations and proposals for legislation. Environmental & health protection lobbying gains momentum when off-the-shelf solutions become available. It is reasonable to expect that the EPA, the insurance industry and many others, including special-interest groups, will take steps to avoid a repeat performance of the asbestos debacle - on any scale. With an isocyanate-free solution now becoming available off-the-shelf, it seems reasonable to expect significant change and adoption... especially one that is proven to be cost-effective while offering performance advantages.

And if you are wondering how the rest of the world might act on eliminating isocyanates from the workplace and, further, from consumer products in general, consider the following.

Many (most?) who read this will already know that polyurethane has unique properties and offers abilities that are very difficult or costly to achieve with any other solution; and that it is used in many, many products with verticals in the marketplace amounting to $xxx billions of dollars - everything from floor/surface coatings to vehicle paints/coatings to home/building insulation to many consumer products incorporating foam or cushioning materials (e.g. garments, shoes, bedding and mattress materials and much more).

This is just an excerpt from one of many sources of information related to the asbestos debacle in this country:
Quote:
"Known as the miracle mineral, asbestos was used for its resiliency against chemical attack and its excellent tensile strength and superior fire-proofing characteristics. The material was used in 3,000 to 5,000 products from the early 1800s through the 1970s.

Recognizing the effects of asbestos on human health, the U.S. Public Health Service recommended guidelines on asbestos exposure as early as 1938.

Cost is a key factor. The original plan was the establishment of a $108 billion trust fund, the costs for which would be paid by corporations being sued and by insurance companies. Although expensive - $108 billion is a lot of money - corporations and insurance companies were willing to pony up in order to have a set price tag on the asbestos liability monster.

By the time the bill got out of committee, the price tag had ballooned from $108 billion to $153 billion. The insurance industry promptly dropped out, saying the cost had grown so high, it was better off with the status quo."
Here's an excerpt from another source referencing asbestos - it's not difficult to imagine PU iso-cyanates in a similar light in the near future (though likely on a smaller scale):
Quote:
"Besides CERCLA, asbestos is regulated as a solid waste under the Resource Conservation and Recovery Act, as a building material under the Toxic Substance Control Act, and as an airborne contaminant under the National Emission Standards for Hazardous Air Pollutants program in accordance with the Clean Air Act. The agency also limits effluent discharges for asbestos fibers in water under the Clean Water Act.

The immediate costs of the regulations to a company's bottom line should drive a practical and astute CEO to require his or her environmental department heads to find EPA-approved environmental technologies that can eliminate hazardous and regulated wastes releases once and for all. The success of this action would help alleviate the regulatory burden, increase the bottom line, solidify stockholder position and steady stock worth. "
...especially when you - or an astute CEO or other party responsible for continuing production or installation of PU for coatings, insulation and/or fabrication of consumer goods - consider statements like the following (slides from Mary Cushman's 2011 presentation - Mary Cushman appointed to HCTI Board of Advisors August 2015):

Hybrid Appoints Retired EPA Section Chief to Board of Advisors

1603632412_CushmacSPFApresentationTitleSlide.jpg
862212491_CushmacSPFApresentationLongTerm.jpg

http://www2.worksafebc.com/i/posters/2010/ws%2010_05.html
https://www.osha.gov/SLTC/isocyanates/
http://www.cdc.gov/niosh/topics/isocyanates/
http://www.safeworkaustralia.gov.au/sites/SWA...anates.pdf
http://www.cdph.ca.gov/programs/hesis/documents/iso.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1849909/
http://www.hse.gov.uk/construction/healthrisk...anates.htm
http://www.cwa-union.org/pages/polyurethanes_..._workplace
https://www.grainger.com/content/qt-233-isocyanate
http://medicine.yale.edu/intmed/prep/worker/h...anate.aspx
http://medicine.yale.edu/intmed/prep/worker/h...ocyanates/
https://polyurethane.americanchemistry.com/He...anates.pdf
http://www.lhsfna.org/index.cfm/lifelines/dec...nsulation/
http://www.arbeidstilsynet.no/binfil/download2.php?tid=77871
http://www2.buildinggreen.com/blogs/epa-raise...insulation (at bottom, mention of HNIPUs being developed; also, good comments at bottom)
http://www.business.govt.nz/worksafe/informat...s-acop-pdf
http://www.actsafe.ca/wp-content/uploads/reso...anates.pdf
http://www.bodyshopbusiness.com/your-lungs-yo...your-life/

Hybrid Appoints Retired EPA Section Chief to Board of Advisors
San Francisco CA, August 27, 2015 -- (MARKET WIRE) – Hybrid Coating Technologies Inc.
(HCTI: OTCBB) is pleased to announce that it has appointed Mary Cushmac to its board of
advisors. Ms. Cushmac who retired from the US EPA in 2011 spent most of her career focusing
on the dangers of isocyanates in the polyurethane industry and was in charge of numerous efforts
to limit the use of isocyanates with the eventual goal of an outright ban (see full bio below). “We
are very happy to add Ms. Cushmac to our board of advisors,” said Joseph Kristul President and
CEO, “Her track record against isocyanates in the polyurethane industry and extensive
experience, brings great expertise to our team and speaks volumes as to the true potential of our
award winning technology.”
Hybrid’s patented technology is the only formulation in the world today that produces
polyurethane without the use of any isocyanates in the entire production process.

About Mary Cushmac
Mary Cushmac has more than 30 years experience at the U.S. Environmental Protection
Agency in the Design for the Environment (DfE) and the New Chemicals programs in the
Office of Pollution Prevention and Toxics. From 1997 until her retirement in 2011, she worked
in partnership with the collision repair industry and career/technical schools to develop and
promote best practices to reduce exposure to isocyanates during spray painting and related
operations. Isocyanates – key chemicals in automotive and industrial coatings – are reported to
be the leading cause of occupational asthma.
Ms. Cushmac played a major role in establishing and leading the Federal Spray Polyurethane
Foam Workgroup with participation by the Occupational Safety and Health Administration
(OSHA), the National Institute for Occupational Safety and Health (NIOSH), the Agency for
Toxic Substances Disease Registry (ATSDR) and the Consumer Product Safety Commission
(CPSC). This work group initiated dialog with the Spray Polyurethane Foam Alliance (SPFA),
the American Chemistry Council (ACC) Center for Polyurethanes Industry (CPI), and the
polyurethane foam industry to promote health and safety best practices that reduce isocyanate
exposures in spray polyurethane foamapplications.
Ms. Cushmac was also a member of the advisory panel created to advise the North Carolina
Division of Public Health and ATSDR on local communications issues related to the 2007-2010
public health study regarding isocyanate (TDI) emissions from a polyurethane plant in North
Carolina.
Ms. Cushmac joined EPA in 1980, serving as the New Chemicals Pre-notice Coordinator and
later as a section chief. She chaired the work group that developed the TSCA Pre-manufacture
Notification Rule Amendments published in 1995, and co-chaired the New Chemicals
Program's Environmental Technology Initiative that developed the 1994 Automotive
Refinishing Industry Isocyanate Profile, which outlines health and safety information on
isocyanates and recommends engineering controls and protective equipment to reduce
inhalation and dermal exposures.
Ms. Cushmac co-authored a discussion of the hazards associated with isocyanate
exposures, best workplace practices, and safer alternatives in a section of the Handbook of
Green Chemistry, Green Processes, Designing Safer Chemicals, published in 2014.
Prior to joining EPA, Ms. Cushmac worked as a research chemist in food chemistry at the
U.S. Food and Drug Administration and published several articles on analytical methods for
detecting toxins in food.
Ms. Cushmac received her undergraduate degree in chemistry at Trinity College in
Washington, D.C. and a Master's degree in organic chemistry at the Catholic University of
America in Washington,D.C. She is a member of the American Chemical Society.

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as
amended and such forward-looking statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Statements in this news release other than
statements of historical fact are "forward-looking statements" that are based on current
expectations and assumptions. Forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from those expressed or implied by the statements,
including, but not limited to, the following: the ability of Hybrid Coating Technologies Inc. to
provide for its obligations, to provide working capital needs from operating revenues, to obtain
additional financing needed for any future acquisitions, to meet competitive challenges and
technological changes, and other risks. Hybrid Coating Technologies Inc undertakes no duty to
update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or
changes in Hybrid Coating Technologies Inc. expectations.

About Hybrid Coating Technologies
Hybrid Coating Technologies (HCT) is a San Francisco-based innovator focused on improving
the quality and safety of foams, coatings, and adhesives for industrial and commercial customers
around the world. We are the exclusive licensee of Green Polyurethane™ foam, coatings, and
adhesives – the world’s first-ever patent protected polyurethane-based foam, coatings, and
adhesive products that eliminate toxic isocyanates from the entire production process (licensed
by Nanotech Industries, Inc.) and the 2015 recipient of the Presidential Green Chemistry Award .

The Problem of Conventional Foams/Coatings/Paint and Isocyanates
Conventional polyurethane (PU) paint and coatings have many disadvantages: they are porous,
permeable and maintain poor hydrolytic stability. This makes the material highly vulnerable to
environmental degradation and ultimately leads to their chemical decomposition, especially
when in contact with water. Conventional PU foams such as spray foam insulation are applied
via a spraying mechanism that sends toxic isocyanates in the air – exposing workers to the
dangers of toxic isocyanates. Strict and costly health & safety measures have to be implemented
in the manufacture and application of conventional polyurethane due to the toxicity of
isocyanates. This is why regulatory bodies around the world are now looking toward phasing out
the use of isocyanates.

The Green Polyurethane™ Solution
Green Polyurethane™ (also referred to as “HNIPU” - hybrid non-isocyanate polyurethane) is a
“hybrid” material that combines the high chemical resistance properties of epoxy and advanced
durability and wear resistance properties of polyurethane, making it the perfect coating
application for sanitary, high traffic and corrosive surface areas. As a hybrid material with
superior properties, Green Polyurethane ™ can be applied in one or two coatings, providing a
welcome cost-saving substitute to currently used multi-layered coating applications. Its safety
features allow it to be applied without the interruption of business due to public exposure,
creating an additional 30-60% savings on application costs for customers. As a foam, Green
Polyurethane™ provides high R values up to 6.0, energy savings up to 30% and improved tensile
strength over conventional foam without using dangerous isocyanates.

Recent Anti-Isocyanate Regulatory Pressure
US EPA MDI Action Plan: The US EPA (Environmental Protection Agency) is taking
progressive action to regulate and potentially ban isocyanates and has mentioned Hybrid’s
technology as an alternative to toxic polyurethane in its MDI Action Plan against isocyanates
(see page 4 Figovsky and Shapovalov)

http://www.epa.gov/oppt/existingchemicals/pub...ns/mdi.pdf
OSHA National Emphasis Program: On June 25, 2013 the Occupational Safety and Health
Administration (OSHA), a division of the US Department of Labor, initiated a National
Emphasis Program
to protect workers from the serious health effects from occupational exposure
to isocyanates. Isocyanates are found in polyurethane based products. According to OSHA,
"Workers exposed to isocyanates can suffer debilitating health problems for months or even
years after exposure which could result in death."

California’s Department of Toxic Substances Control (DTSC) on March 13, 2014 selected
isocyanates and two others substances from a list of 1,100 toxic components that it will focus on
with the goal of potentially banning them altogether within the next two years. The
announcement is part of a bigger effort to educate consumers and manufacturers about product
safety under the Green-Chemistry Law, which went into effect in California last year. Under the
law, the agency has jurisdiction to ban these products altogether after following proper protocol.
That process includes workshops, a public comment period and requiring manufacturers that
want to sell these products in California to determine whether it would be feasible to use
safer ingredients.

The US EPA on January 8, 2015 announced that it was taking action to protect consumers from
new uses and imports of harmful isocyanates in polyurethane.
The EPA’s proposed action, a
Significant New Use Rule (SNUR) under the Toxic Substances Control Act (TSCA), would
require manufacturers (including importers) to notify the EPA at least 90 days before starting or
resuming new uses of isocyanates in polyurethane based consumer products. The EPA would
then have the opportunity to evaluate the intended use of and if necessary, to take action to
prohibit or limit all products containing over one tenth of one percent of the chemical including
imported products that make their way into the United States

Public and Media Relations:
LCG
Vanessa Luna
702-761-6967

Hybrid Coating Technologies, Inc. (HCTI) Stock Research Links

HCTI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading